Wang et al. found that the DDR key gene BRCA1 could be inhibited by XPC inhibition in BLCA, which could lead to increased chromosomal instability and maintaining cisplatin-induced DNA damage [68]. The gene discussed is BRCA1; the disease is bladder transitional cell carcinoma.